CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.390
-0.009 (-0.38%)
Apr 24, 2025, 11:12 AM EDT - Market open
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $27.12 million as of April 25, 2025. Its market cap has increased by 5.01% in one year.
Market Cap
27.12M
Enterprise Value
22.40M
1-Year Change
5.01%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $27.12M, a decrease of -41.20%. That is a compound annual growth rate of -23.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 27.69M | -29.44% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.65B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.10B |
| AbbVie | 313.02B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.15B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |